CAN-FITE BIOPHARMA LTD's ticker is CANF and the CUSIP is 13471N102. A total of 7 filers reported holding CAN-FITE BIOPHARMA LTD in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $12,000 | -29.4% | 13,700 | 0.0% | 0.00% | – |
| Q4 2018 | $17,000 | -5.6% | 13,700 | 0.0% | 0.00% | – |
| Q3 2018 | $18,000 | +12.5% | 13,700 | 0.0% | 0.00% | – |
| Q2 2018 | $16,000 | -20.0% | 13,700 | 0.0% | 0.00% | – |
| Q1 2018 | $20,000 | +11.1% | 13,700 | +12.3% | 0.00% | – |
| Q4 2017 | $18,000 | -14.3% | 12,200 | 0.0% | 0.00% | – |
| Q3 2017 | $21,000 | -4.5% | 12,200 | 0.0% | 0.00% | – |
| Q2 2017 | $22,000 | – | 12,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TAYLOR ASSET MANAGEMENT INC | 796,500 | $1,434,000 | 0.48% |
| Psagot Value Holdings Ltd. | 34,126 | $61,000 | 0.00% |
| Virtu KCG Holdings LLC | 21,565 | $39,000 | 0.00% |
| MORGAN STANLEY | 12,300 | $22,000 | 0.00% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 800 | $1,000 | 0.00% |
| Citadel Advisors | 16,738 | $30,000 | 0.00% |
| RAYMOND JAMES & ASSOCIATES | 12,200 | $22,000 | 0.00% |